The EMC trial investigates for the first time prospectively whether Major Depression Disorder
patients with non-improvement after 14 days of antidepressive treatment with EMC are more
likely to become remitters compared to patients treated according to current guidelines,
i.e., with a medication change after 28 days of treatment in case of non-response.